Use of evidence-based management for acute coronary syndrome

New Zealand Medical Journal

Volumn 118, Issue 1223, 2005, Pages

  Tang, Eng Wei ^a   Wong, Cheuk Kit ^a   Wilkins, Gerard ^a   Herbison, Peter ^a   Williams, Michael ^a   Kay, Patrick ^a   Restieaux, Norma ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; DYSLIPIDEMIA; EVIDENCE BASED MEDICINE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; PATIENT COMPLIANCE; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRESCRIPTION; REGISTER; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; ACUTE DISEASE; AGED; CARDIOLOGY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; FEMALE; FIBRINOLYTIC THERAPY; MALE; METHODOLOGY; NEW ZEALAND; RETROSPECTIVE STUDY; STANDARD; STATISTICS; UTILIZATION REVIEW;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTICOAGULANTS; ASPIRIN; CARDIOLOGY; CORONARY ANGIOGRAPHY; CORONARY DISEASE; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HEPARIN; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MYOCARDIAL REVASCULARIZATION; NEW ZEALAND; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES; THROMBOLYTIC THERAPY; TICLOPIDINE;

EID: 27744476685     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ryan TJ, Antman EM, Brooks NH, et al. 1999 Update: ACC/AHA Guidelines for the management of patients with acute myocardial infarction: Executive Summary and recommendations. Circulation. 1999;100:1016-30.
2. Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non ST-segment elevation myocardial infarction: Summary article. Circulation. 2002;106:1893-1900.
3. Lenfant C. Clinical research to clinical practice - lost in translation? N Engl J Med. 2003; 349:868-74.
4. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 2003;41:56-61.
5. EUROASPIRE II Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554-572.
6. Fox KA, Goodman SG, Klein W, et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2002;23:1177-89.
7. Calvin JE, Roe MT, Chen A, et al. Higher mortality and less evidence-based therapies among Medicaid-insured patients with high-risk acute coronary syndrome: Results from CRUSADE. Abstract. J Am Coll Cardiol. 43, Suppl 2, 2004. Page A413.
8. Ellis C, Gamble G, French J, et al. Management of patients admitted with an acute coronary syndrome in New Zealand: results of a comprehensive nationwide audit. NZ Med J. 2004;117(1197). URL: http://www.nzma.org.nz/journal/117-1197/953 Accessed September 2005.
9. Otago-Southland Regional Labour Market Reports; July 2004. Available online. URL: http://www.dol.govt.nz/PDFs/Otago-Southland.pdf Accessed September 2005.
10. Ellis C, Devlin G, French J, et al. Acute coronary syndrome patients in New Zealand receives less invasive management when admitted to hospitals without invasive facilities. NZ Med J. 2004;117:1197. Available online. URL: http://www.nzma.org.nz/journal/117-1197/954 Accessed September 2005.
11. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and inhospital outcome of patients hospitalizes with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002;90:358-63.
12. Fox KA, Goodman SG, Anderson FA, et al. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003;24:1414-24.
13. Jonsson B, Johannesson M, Kjekshus J, et al. Cost-effectiveness of cholesterol lowering. Results from the Scandinavian Simvastatin Survival Study (4S). Eur Heart J. 1996;17:1001-07.
14. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
15. The Heart Outcome Prevention Evaluation (HOPE) study investigators. Effects of an angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342:145-53.
16. Pfeffer MA, Swedberg K, Granger CB, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-OVERALL programme. Lancet. 2003;362:759-66.
17. The EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782-88.
18. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina - summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41:159-68.
19. Lopez-Sendon J, Swedberg K, McMurray J, et al. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J. 2004;25:1454-70.
20. The PEACE Trial investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058-68.
21. Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q-wave myocardial infarction. J Am Coll Cardiol. 1995;26:1643-50.
22. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive compared with a conservative management strategy. N Engl J Med. 1998;338:1785-92.
23. Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. Lancet. 2000;356:9-16.
24. Cannon CP, Weintraub WS, Demopoulos LA, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. N Engl J Med. 2001;344:1879-87.
25. Fox KAA, Poole-Wilson PA, Henderson RA, et al. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Lancet. 2002;360:743-51.
26. Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndrome without ST-segment elevation. N Engl J Med. 2001;345:494-02.
27. Francisco Avilés F, Alonso JJ, Castro-Beiras A, et al. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364:1045-53.
28. Birkhead JS, Walker L, Pearson M, et al on behalf of the MINAP Steering Group. Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart. 2004;90:1004-09.
29. Mukherjee D, Fang J, Chetcuti S, et al. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation. 2004;109:745-49.
30. Schiele F, Meneveau N, Seronde MF, et al. Compliance with guidelines and 1-year mortality in patients with acute myocardial infarction: a prospective study. Eur Heart J. 2005;26:873-80.